JPMorgan Chase & Co. Purchases 218,941 Shares of DocGo Inc. (NASDAQ:DCGO)

JPMorgan Chase & Co. grew its holdings in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 199.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 328,796 shares of the company's stock after purchasing an additional 218,941 shares during the quarter. JPMorgan Chase & Co. owned about 0.32% of DocGo worth $1,394,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. State Street Corp boosted its holdings in DocGo by 4.9% in the 3rd quarter. State Street Corp now owns 1,928,972 shares of the company's stock worth $6,404,000 after buying an additional 90,438 shares during the period. Barclays PLC grew its position in shares of DocGo by 279.7% in the third quarter. Barclays PLC now owns 134,923 shares of the company's stock valued at $447,000 after purchasing an additional 99,387 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of DocGo by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,252,516 shares of the company's stock valued at $7,480,000 after purchasing an additional 39,016 shares during the period. Franklin Resources Inc. lifted its holdings in DocGo by 11.6% during the 3rd quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company's stock worth $3,933,000 after purchasing an additional 124,348 shares in the last quarter. Finally, Harbor Capital Advisors Inc. boosted its stake in DocGo by 37.5% in the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after purchasing an additional 363,391 shares during the period. Hedge funds and other institutional investors own 56.44% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DCGO. Needham & Company LLC restated a "buy" rating and issued a $4.00 price objective on shares of DocGo in a research report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a "buy" rating to a "hold" rating and reduced their price target for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Finally, Stifel Nicolaus reduced their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $4.89.

DocGo Stock Up 1.8 %

Shares of NASDAQ DCGO traded up $0.04 during trading hours on Tuesday, reaching $2.28. 499,581 shares of the stock traded hands, compared to its average volume of 747,335. The company's 50-day simple moving average is $2.83 and its two-hundred day simple moving average is $3.76. The company has a market capitalization of $232.52 million, a P/E ratio of 8.14, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. DocGo Inc. has a 52-week low of $2.02 and a 52-week high of $5.68.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.